Signaiture provides an AI‑enhanced dielectric sensing platform that delivers real‑time, non‑destructive quality testing for pharmaceutical powders, tablets, and liquids. By measuring electromagnetic signatures and applying machine‑learning models, the system offers bulk property analysis, instant pass/fail decisions, and compliance‑ready reporting directly on the production line, eliminating the need for off‑site labs and reducing waste.
Funding
Funding not disclosed
Founders
Product
Problem
Pharmaceutical manufacturers rely on optical or chemical testing methods that are often destructive, surface‑limited, and require lengthy off‑site analysis, leading to delayed release, high waste, and reliance on external labs.
Solution
Signaiture offers an AI‑enhanced dielectric sensing platform that performs real‑time, non‑destructive quality testing across the full depth of powders, tablets, and liquids. By measuring electromagnetic signatures and applying machine‑learning models, the system detects moisture variations, composition inconsistencies, and contaminants without sample preparation. The hardware integrates directly into production lines, while the SaaS AI layer provides instant analytics and compliance reporting, reducing lead times and eliminating the need for outsourcing. The solution aligns with existing regulatory frameworks, delivering transparent, traceable quality control throughout the manufacturing process.
Target Audience
Primary customers are branded and generic pharmaceutical manufacturers seeking in‑process, high‑throughput quality control for powders, tablets, and liquid formulations.
Features
- Dielectric spectroscopy sensor that penetrates 100 % of the sample, enabling bulk property measurement rather than surface‑only analysis
- AI models that interpret electromagnetic signatures in real time for immediate pass/fail decisions
- Edge‑computing architecture that processes data on‑site, minimizing latency and hardware investment
- Seamless integration with existing production equipment and compliance systems (e.g., GMP, FDA)
- Cloud‑based SaaS dashboard for continuous monitoring, trend analysis, and audit‑ready reporting
- Non‑destructive testing eliminates sample waste and removes the need for chemical reagents